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Summary
Myc family transcription factors are destabilized by
phosphorylation of a conserved amino-terminal GSK-
3 motif. In proliferating cerebellar granule neuron
precursors (CGNPs), Sonic hedgehog signaling in-
duces N-myc expression, and N-myc protein is stabi-
lized by insulin-like growth factor-mediated suppres-
sion of GSK-3. N-myc phosphorylation-mediated
degradation is a prerequisite for CGNP growth arrest
and differentiation. We investigated whether N-myc
phosphorylation and turnover are thus linked to cell
cycle exit in primary mouse CGNP cultures and the
developing cerebellum. We report that phosphoryla-
tion-induced turnover of endogenous N-myc protein
in CGNPs increases during mitosis, due to increased
priming phosphorylation of N-myc for GSK-3. The
priming phosphorylation requires the Cdk1 complex,
whose cyclin subunits are indirect Sonic hedgehog
targets. These findings provide a mechanism for pro-
moting growth arrest in the final cycle of neural pre-
cursor proliferation competency, or for resetting the
cell cycle in the G1 phase, by destabilizing N-myc in
mitosis.
Introduction
Signaling by hedgehog family members regulates pro-
liferation, cell fate specification, and differentiation in a
variety of tissues during development (Roy and Ingham,
2002; Rubin and Rowitch, 2002). Specific links between
hedgehog, which has not as yet been reported to acti-
vate a receptor tyrosine kinase like many other growth
factors (Lum and Beachy, 2004; Schwartz and Baron,
1999), and the cell cycle apparatus are still being eluci-
dated. Much insight into mechanisms through which
hedgehog signaling regulates proliferation has been
gained through study of cerebellar granule neuron pre-
cursors (CGNPs) (Rubin and Rowitch, 2002). CGNPs re-
quire Sonic hedgehog (Shh) signaling for proliferation*Correspondence: kenneya@mskcc.org
4 Present address: Department of Cancer Biology and Genetics,
Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New
York, New York 10021.during their expansion phase in vivo and in primary cul-
ture (Wechsler-Reya and Scott, 1999).
The protooncogene transcription factor N-myc is a
direct target of Shh in CGNPs (Kenney et al., 2003; Oli-
ver et al., 2003). Tissue-specific knockout or inhibition
of N-myc function in CGNPs results in early cell cycle
exit and precocious differentiation (Kenney et al., 2003;
Knoepfler et al., 2002; Oliver et al., 2003). N-myc has
been associated with the childhood brain tumor medul-
loblastoma (Pomeroy et al., 2002), which arises from
CGNPs and can be caused by activating mutations in
the Shh pathway (Provias and Becker, 1996; Rubin and
Rowitch, 2002). Increased understanding of N-myc
mRNA and protein regulation in neural precursors is
critical for understanding how downstream effectors of
Shh regulate normal cerebellar development and med-
ulloblastoma formation and/or growth.
Phosphorylation by GSK-3β results in myc destabili-
zation (Gregory et al., 2003; Kenney et al., 2004; Sears
et al., 2000; Welcker et al., 2004; Yada et al., 2004).
GSK-3β requires a previous “priming” phosphorylation
at a serine or threonine residue four amino acids down-
stream from its target site (Cohen and Frame, 2001).
N-myc protein is stabilized by mutation of the GSK-3β
site (T50) and/or the priming site (S54) to nonphos-
phorylatable alanine residues (Kenney et al., 2004). Ret-
rovirus-mediated overexpression of nonphosphorylata-
ble N-myc mutants delays cell cycle exit and prolongs
proliferation in CGNPs (Kenney et al., 2004). Character-
ization of the GSK-3β priming site in myc has been in-
tensely controversial, with conflicting functions and
multiple kinases proposed (Henriksson et al., 1993;
Hoang et al., 1995; Lutterbach and Hann, 1994, 1999;
Niklinski et al., 2000; Noguchi et al., 1999; Pulverer et
al., 1994; Sears et al., 2000; Yeh et al., 2004). Nearly all
studies of myc phosphorylation and turnover have
been performed in cell lines. However, myc protein
phosphorylation differs between primary and trans-
formed cell lines (Lutterbach and Hann, 1997), and very
little is understood about how posttranslational modifi-
cation regulates endogenous myc protein turnover in
primary cells and in vivo.
We investigated how phosphorylation of endogenous
N-myc regulates its activity in the developing nervous
system by using primary CGNP cultures. These cultures
have an advantage over cell lines in that they closely
recapitulate in vivo cell cycle progression, growth ar-
rest, and differentiation processes (Gao et al., 1991;
Kenney and Rowitch, 2000). CGNP survival in vitro de-
pends on constitutive activation of the PI-3 kinase
pathway (Dudek et al., 1997), which is maintained by
insulin or insulin-like growth factor. CGNP proliferation,
and N-myc expression, are dependent upon Shh (Dah-
mane and Ruiz-i-Altaba, 1999; Kenney et al., 2003; Ken-
ney and Rowitch, 2000; Oliver et al., 2003; Wechsler-
Reya and Scott, 1999). In the absence of Shh, CGNPs
differentiate into mature glutamatergic neurons (Altman
and Bayer, 1997).
We show here that N-myc S54 phosphorylation is en-
hanced in mitotic CGNPs in vivo and culture, and we
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tion is accompanied by increased N-myc turnover dur-
ing mitosis in primary neural precursor cells. This phos-
phorylation is required for N-myc turnover in CGNPs
arrested in mitosis. Further, we present evidence that
phosphorylation of N-myc at S54 in vivo during mitosis
is regulated by the Cdk1 complex. Together, these data
identify a mechanism for coordinating Shh-mediated
N-myc induction and turnover during development,
wherein N-myc is phosphorylated and primed for deg-
radation during mitosis in proliferating neuronal precur-
sors. We propose that mitotic phosphorylation-depen-
dent N-myc turnover permits cell cycle exit and
commencement of differentiation at the conclusion of
proliferation competency.
Results
Phosphatase Inhibition Increases Levels
of Endogenous N-Myc S54 Phosphorylation
We have shown that mutating N-myc S54 to alanine
stabilizes N-myc (Kenney et al., 2004), and this finding
is consistent with an inability of GSK-3β to phosphory-
late N-myc at T50 in the absence of a priming phos-
phorylation at S54 (Cohen and Frame, 2001). Con-
versely, increased S54 phosphorylation is predicted to
destabilize N-myc. S62, the c-myc priming site, is a
substrate for PP2A (Yeh et al., 2004). We subjected
Shh-treated CGNPs to a cycloheximide (chx) pulse in
the presence of the PP1/PP2A inhibitors okadaic acid
(OA) or Calyculin A (CalA) (Honkanen and Golden,
2002). After 45 min of chx treatment, N-myc protein
levels in Shh-treated CGNPs were reduced, consistent
with N-myc’s half-life of 30–50 min (Slamon et al., 1986).
High concentrations of OA or CalA accelerated N-myc
protein turnover (Figure 1A).
Several hours of OA treatment reportedly stabilizes
overexpressed c-myc in the cell line REF52 (Yeh et al.,
2004), a finding at variance with our observations in pri-
mary neuronal precursor cells. To determine whether
N-myc stability recovered under conditions of longer
PP1/PP2A inhibition, we repeated the chx chase exper-
iment in the presence or absence of OA over a longer
time course. As shown (Figure 1B), OA treatment per-
sistently decreased endogenous N-myc protein levels
in CGNPs. To further establish a role for PP2A in regu-
lating N-myc protein levels, we infected CGNPs with
retroviruses expressing the SV40 small T antigen, which
specifically inhibits PP2A by displacing the B regulatory
subunit of PP2A (Chen et al., 2004). Ectopic expression
of Small T in CGNPs resulted in substantially reduced
levels of endogenous N-myc (Figure 1C). Taken to-
gether, these observations suggest that, in CGNPs,
N-myc protein is highly sensitive to levels of PP2A ac-
tivity.
N-myc destabilization in the presence of phospha-
tase inhibitors was accompanied by an upward molec-
ular weight shift. To determine whether the upwardly
shifted species contained S54-phosphorylated N-myc,
we generated polyclonal antibodies against S54-phos-
phorylated N-myc (Figure S1; see the Supplemental
Data available with this article online; Figure 3A). These
antibodies recognize N-myc phosphorylated at S54,
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Cegardless of whether it is phosphorylated at T50. We
bserved S54 phosphorylation in Shh-treated, cycling
GNPs, and addition of OA resulted in a high degree of
hosphorylation on S54 (Figure 1D), with a concomitant
eduction in total N-myc protein levels. The proteosome
nhibitor lactacystin prevented the OA-induced decline
n N-myc protein (Figure 1D), suggesting that PP2A in-
ibition promotes increased N-myc proteolysis. We
bserved T50 phosphorylation in the presence of lacta-
ystin, suggesting that this species is degraded in OA-
reated CGNPs. Retrovirally expressed N-myc S54A
as comparatively resistant to OA-induced N-myc de-
tabilization (Figure 1E). Taken together, our observa-
ions indicate that blocking PP2A activity promotes in-
reased N-myc S54 phosphorylation and destabilizes
-myc in primary neuronal precursors.
-Myc Phosphorylation or CGNP Proliferation
n Vivo Are Not Affected by Pin1
ur finding that PP2A inhibition destabilizes N-myc in
rimary neuronal cultures contrasts with a recent report
howing that PP2A inhibition stabilizes c-myc when it
s overexpressed in the REF52 cell line (Yeh et al., 2004).
his study suggested that the prolyl isomerase Pin1 de-
tabilized overexpressed c-myc in REF52 cells by de-
hosphorylating S62. We investigated whether Pin1
egulates endogenous N-myc phosphorylation in neural
recursors. Pin1 is present in CGNPs, and manipulation
f several pathways implicated in CGNP proliferation
nd survival do not affect Pin1 protein levels (Figure
A). Pull-down assays, using GST-Pin1 fusion protein-
inked beads and lysates from proliferating (Shh-
reated) and nonproliferating (vehicle-treated) CGNPs,
emonstrate that Pin1 can interact with endogenous
-myc in Shh-treated CGNPs (Figure 2B). GST beads
lone did not interact with N-myc (data not shown).
ST-Pin1 beads strongly interacted with N-myc, N-myc
50A, and N-myc S54A in lysates prepared from retrovi-
ally infected CGNPs (Figure 2C), showing that S54
hosphorylation is not required for Pin1 to interact with
-myc. Thus, the nature of Pin1:N-myc interactions in
rimary neural precursors differs from that of Pin1:
-myc interactions in fibroblasts.
If Pin1:N-myc interactions promote N-myc turnover
s predicted by the work of Yeh and colleagues, loss
f Pin1 should increase N-myc activity and cause en-
anced proliferation of CGNPs in the developing cere-
ellum. Enhanced CGNP proliferation in vivo is not le-
hal and can be detected through postnatal analysis of
he cerebellum (Miyazawa et al., 2000; Ye et al., 1996).
t postnatal day 5 (PN5), when CGNPs are undergoing
igorous proliferation (Altman and Bayer, 1997), the cer-
bella of wild-type and Pin1 null (Liou et al., 2002) litter-
ates were histologically indistinguishable (Figures 2D
nd 2E). Wild-type and Pin1 null mice exhibited compa-
able levels of proliferating cell nuclear antigen (PCNA)
n the EGL (primary fissure [arrow, and inset, magnified
0× for images shown in Figures 2D and 2E]). We de-
ected no differences in levels of BrdU incorporation
etween Pin1 null and wild-type animals. Quantitation
f phosphohistone H3 staining revealed no statistically
ignificant difference between the numbers of mitotic
GNPs in the primary fissure of mutant (38 ± 5) and
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329Figure 1. Phosphatase Inhibition Destabi-
lizes Endogenous N-Myc and Promotes S54
Phosphorylation
(A) Western blot analysis of N-myc protein in
primary CGNPs cultured in the presence of
Shh (3 g/ml) for 24 hr before a 45 min treat-
ment with cycloheximide (“Chx,” 10 g/ml)
and phosphatase inhibitors as indicated.
Control cells (“−”) were treated with PBS, the
Shh vehicle, or DMSO, which is the solvent
for chx, OA, and CalA.
(B) Western blot time course showing contin-
ued enhancement of endogenous N-myc de-
stabilization by PP1/PP2A inhibition. CGNPs
were cultured with Shh for 24 hr before treat-
ment with chx and/or OA as indicated.
(C) CGNPs were infected with retroviruses
expressing Small T, then maintained in the
presence of Shh for 24 hr postinfection.
Levels of N-myc protein and Small T protein
are shown, with β-tubulin levels indicating
similar loading of the lanes.
(D) CGNPs were treated with OA (1 hr), in the
presence or absence of the proteosome in-
hibitor lactacystin. Lactacystin prevented
OA-induced N-myc protein decrease. West-
ern blotting with anti-phospho-T50 N-myc
shows that this species is degraded. Phos-
pho-S54 N-myc levels increase in the pres-
ence of OA.
(E) 24 hr after infection with retroviruses ex-
pressing N-myc or nonphosphorylatable
N-myc S54A, CGNPs were subjected to a 1
hr treatment with OA, as indicated above the
lanes. Protein lysates were immunoblotted
for N-myc and β-tubulin.wild-type (36 ± 6) animals. Therefore, by these three
measures, CGNP proliferation is normal in the cerebella
of Pin1 null animals, suggesting that mediators of cell
cycle progression, such as N-myc, are not disregulated
in this tissue.
To determine whether Pin1 promotes N-myc dephos-
phorylation in vivo, we performed immunostaining for
N-myc phosphorylated at S54 in PN5 Pin1 wild-type
and null mouse cerebella. Anti-phospho-S54 N-myc im-
munoreactivity in Pin1 wild-type and null animals was
localized to mitotic cells (Figure 2F). We found no sig-
nificant difference in the numbers of CGNPs positive
for S54-phosphorylated N-myc when we quantified
N-myc S54 phosphorylation in EGL cells in the primary
fissure as described above (−/−32 ± 3 versus +/+34 ± 3).
These results show that Pin1 is unlikely to regulate
N-myc S54 dephosphorylation in the developing cere-
bellum, suggesting that the earlier c-myc overexpres-
sion/cell line studies are not generalizable to endo-
genous N-myc regulation in primary cells or in the
developing brain.
S54 Phosphorylation Increases and Total N-Myc
Levels Decline in Mitotic CGNPs
Our observation of increased N-myc S54 phosphory-
lation in mitotic CGNPs in vivo suggested that S54
phosphorylation is cell cycle regulated. To better char-
acterize the cell cycle regulation of N-myc S54 phos-
phoryation, we costained Shh-treated CGNP cultures
with antibodies against phospho-S54 N-myc and phos-pho-histone H3. Consistent with our observations in the
developing cerebellum, we observed strong phospho-
S54 N-myc immunoreactivity in cells undergoing mito-
sis (Figure 3A), as determined by chromatin condensa-
tion. Cells in early and late phases of mitosis with high
levels of S54 phosphorylation were seen. Competition
with phosphorylated peptides eliminated antibody stain-
ing (Figure 3A).
To determine when during mitosis N-myc S54 is
phosphorylated, we used immunofluorescent staining
to compare N-myc S54 phosphorylation with histone
H3 phosphorylation, which takes place during early
prophase (Hans and Dimitrov, 2001). Cells whose chro-
matin condensation indicated early prophase were only
positive for phospho-histone H3 (Figures 3A and 3B).
In contrast, phospho-S54 N-myc alone was found in
late-phase mitosis cells. Phospho-S54 N-myc immuno-
reactivity became detectable during the prophase-to-
metaphase transition. N-myc phosphorylated at S54
segregated away from the condensed chromosomes,
consistent with studies showing that phosphorylated
myc does not bind to DNA (Luscher and Eisenman,
1992). Costaining for phospho-S54 N-myc and β-tubulin,
to monitor spindle formation, confirmed that N-myc
phosphoryation begins in late prophase and can be de-
tected until cytokinesis (Figure 3C).
Phospho-S54 N-myc immunoreactivity was low in
vehicle-treated CGNPs (Figure 3D), as expected, since
N-myc is not expressed in nonproliferating CGNPs. En-
hanced N-myc S54 phosphorylation in mitotic CGNPs
Developmental Cell
330Figure 2. Pin1:N-Myc Interactions Are Not Specific for S54 and Do Not Affect CGNP Proliferation or N-Myc S54 Phosphorylation In Vivo
(A) Western blot showing that Pin1 is expressed in cultured granule neurons and that its levels do not change in response to manipulation of
signal transduction pathways affecting CGNP proliferation and/or survival. CGNPs were cultured in the presence or absence of Shh, then
treated with the PI-3 kinase inhibitor wortmannin (100 nM), the MEK inhibitor PD98059 (10 M), or brain-derived neurotrophic factor (BDNF,
100 ng/ml) for 24 hr before harvesting.
(B) Pull-down assay showing that endogenous N-myc from CGNPs can interact with GST-Pin1. CGNPs were treated with Shh for 24 hr before
harvest and preparation of lysates. A total of 100 g protein was incubated with GST-Pin1 beads or GST beads alone, then processed for
Western blotting as indicated.
(C) Pull-down assay showing that wild-type and phospho mutant N-myc can interact with GST-Pin1. CGNPs were infected with retroviruses
expressing the indicated N-myc or mutant N-myc. After infection, CGNPs were grown in medium lacking Shh, so that the pulled-down protein
would represent only the overexpressed constructs. Pin1 pull-down assays were performed as described above.
(D) The leftmost panel shows PN5 midline cerebellar section from a wild-type mouse stained with Dapi to demonstrate cerebellar foliation.
The arrow indicates the primary fissure. The white box shows the area of magnification for immunofluorescence analysis of PCNA expression,
BrdU incorporation, and histone H3 phosphorylation shown in the right-hand panels. Immunfluorescence is green; Dapi (blue) is the counter-
stain.
(E) The leftmost panel shows PN5 midline cerebellar section from a Pin1−/− littermate, stained with Dapi to demonstrate EGL formation and
cerebellar foliation. The arrow indicates the primary fissure. The white box shows the area of magnification for immunofluorescence analysis
as in (D).
(F) Immunofluorescence staining for phospho-S54 N-myc (red, blue Dapi counterstain) in the EGL of a wild-type PN5 pup and a Pin1−/−
littermate. High magnification image of the EGL at the midpoint of the primary fissure; the arrow indicates the direction toward the inner
granule layer.(Figures 2 and 3A–3D) suggests that the activity of a
potent N-myc S54 kinase is upregulated during mitosis.
We asked how N-myc protein localization and levels
compare with those of phospho-S54 N-myc in CGNPs.
As shown in Figures 3D and 3E, total N-myc protein is
nuclear in interphase CGNPs, while S54-phosphory-
lated N-myc is not detectable. We observed colocaliza-
tion of N-myc with phospho-S54 N-myc in late pro-
phase and metaphase CGNPs. Detectable total N-myc
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Tprotein declined in late-phase mitotic CGNPs, and thathich remained was heavily phosphorylated on S54.
hus, in proliferating CGNPs, total N-myc protein levels
re reduced during the progression through mitosis in
ssociation with increased levels of S54 phosphory-
ation.
he Cdk Complex Phosphorylates MYCN
54 in SJ8 Neuroblastoma Cells
o generate high numbers of cells in specific cell cyclephases for preliminary biochemical characterization of
N-Myc Phosphorylation/Turnover in Mitosis
331Figure 3. N-Myc Phosphorylation at S54 in Cultured Cerebellar Granule Neuron Precursors Occurs in Mitotic Cells and Is Associated with
Reduced Levels of N-Myc Protein
(A) Comparison of histone H3 phosphorylation and N-myc S54 phosphorylation shows that N-myc phosphorylation begins during late pro-
phase and persists through mitosis. CGNPs were costained for phosphohistone H3 (green), phospho-S54 N-myc (red), and Dapi (blue). Mitosis
phases indicated are: P, prophase; P/M, prometaphase; M, metaphase; A, anaphase. Competition with phospho-S54 and phospho-T50/S54
peptides eliminated antibody binding, while competition with a nonphosphorylated peptide did not.
(B) Quantiation of costaining with anti-phospho-histone H3 and anti-phospho-S54 N-myc shows that N-myc phosphorylation begins in late
prophase. See Supplemental Experimental Procedures for quantitation procedure. Singly phospho-H3-positive cells were observed in pro-
phase, while singly phospho-S54 N-myc-positive cells were observed in cytokinesis. Doubly positive cells appeared in late prophase
through metaphase.
(C) N-myc S54 phosphorylation lasts through mitosis, as determined by spindle formation. CGNPs were stained for phospho-S54 N-myc (red)
and tubulin (green) and were counterstained with Dapi (blue). Mitosis phase is indicated in each panel.
(D) Primary cerebellar granule neuron precursors were treated with PBS (left panel) or Shh (middle) for 24 hr, then processed for immuno-
staining with anti-phospho-S54 N-myc (red) and counterstained with Dapi (blue). The right panel shows costaining for total N-myc (green)
and phospho-S54 N-myc (red). N-myc immunoreactivity is seen in interphase cells and mitotic cells until metaphase. Phospho-S54 N-myc
alone is detected in late-mitosis cells.
(E) CGNPs were costained with anti-N-myc and anti-phospho-S54 N-myc, then immunopositive cells were quantified as in (B). The chart
shows which phases contained cells singly or doubly positive for each antibody. Cells not expressing N-myc or phospho-S54 N-myc are
assumed to have left the cell cycle and to have begun differentiation, consistent with an intrinsic program for maturation (see Discussion).the mitotically active S54 kinase, we resorted to a neu-
roblastoma cell line, due to the unfeasability of syn-
chronizing primary neural precursors. We treated SJ8
neuroblastoma cells, which bear >25 copies of the
MYCN gene (Teitz et al., 2000) with nocodazole (ndz), a
microtubule depolymerizing agent that arrests cells in
M phase. We used flow cytometry to monitor the accu-
mulation of cells in mitosis during treatment with ndz
(Figure 4A).
The sequence surrounding S54 is a consensus se-
quence for phosphorylation by kinases of the MAPK
and cyclin-dependent kinase (Cdk)1 families (Lutter-bach and Hann, 1994). In vitro, MAPK, JNK, and Cdk1
can phosphorylate c-myc at S62, although biological
roles for these kinases in regulating myc phosphoryla-
tion remain controversial (Lutterbach and Hann, 1994,
1999; Noguchi et al., 1999). The neuronal-specific Cdk5
is closely related to Cdk1 and has been reported to
have mitotic kinase-like activity (Hamdane et al., 2003).
We assayed the ability of Erk, JNK, Cdk5, Cdk1, and
Cdk1’s mitotic partners cyclin A and cyclin B1 (Nigg,
2001) immunoprecipitated from SJ8 cells to phosphor-
ylate a wild-type N-myc GST fusion protein or an N-myc
S54A GST fusion protein.
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332Figure 4. Cyclin B1/Cdk1 Phosphorylates
N-Myc in G2/M-Arrested Neuroblastoma
Cells
(A) The left panel shows flow cytometry plots
illustrating cell cycle distribution of SJ8 cells
in the absence (top) or presence (bottom) of
nocodazole (ndz, 100 ng/ml). The right panel
shows immunoprecipitation kinase assays
showing the activity of Erk, JNK, Cdk5,
cyclin A, cyclin B1, and Cdk1 toward full-
length GST-N-myc, N-myc S54A, or positive
control substrates.
(B) SJ8 cells were treated with 100 ng/ml ndz
as indicated to promote accumulation in
G2/M. Roscovitine (10 M), the Cdk inhibitor,
or PD90259 (10 M), the MEK inhibitor, were
added at the time ndz treatment was initi-
ated. Lysates were immunoblotted for the in-
dicated proteins.
(C) Western blots showing that acute Cdk in-
hibition in G2/M-arrested SJ8 cells reduces
S54 phosphorylation. Cells were treated with
ndz for the indicated times before the addi-
tion of roscovitine for 1 hr. The distribution
of cells in G1 and G2/M, determined by flow
cytometry, is indicated below the Western
blots.
(D) Western blots showing that Cdk1 knock-
down abrogates N-myc S54 phosphorylation
in neuroblastoma cells in response to ndz
treatment. Cells were infected with control len-
tiviruses or lentiviruses expressing shRNA
against Cdk1, then treated with ndz at the indi-
cated time postinfection. Control treatment
was performed at 72 hr postinfection. Cdk1
protein levels in control and Cdk1-specific
shRNA lentivirus-infected cells are shown.
The distribution of cells in G1 and G2/M, de-
termined by flow cytometry, is indicated be-
low the Western blots.
(E) Immune-complex kinase assay results showing that Cdk2 immunoprecipitated from neuroblastoma cells can phosphorylate wild-type
N-myc and also S54A mutant N-myc, indicating that Cdk2 is not specific for S54. Aphidicolin (5 g/ml, 12 hr) was used to arrest cells at the
G1/S boundary. Histone H1 is shown as a positive control.
(F) Western blot (top) and FACS analysis (bottom) of N-myc phosphorylation and cell cycle progression in neuroblastoma cells arrested at
the G1/S boundary, a period of high cyclin E:Cdk2 activity, or at G2/M, a period of high cyclin A and B:Cdk1 activity.Phosphorylation of the control substrates shows that
the tested kinases were active (Figure 4A). Immuno-
precipitated Erk phosphorylated GST-N-myc. However,
Erk also phosphorylated GST-N-myc S54A, indicating
that Erk’s activity toward N-myc is not restricted to S54.
JNK showed no activity toward wild-type or mutated
N-myc. Interestingly, Cdk5 showed evidence of activity
toward wild-type N-myc, but, like Erk, it also phosphor-
ylated S54A-mutated N-myc, indicating that Cdk5’s ac-
tivity toward N-myc is not specific for S54. The Cdk1-,
cyclin A-, and cyclin B1-immunoprecipitated com-
plexes robustly phosphorylated GST-N-myc. Moreover,
the activity brought down with Cdk1/cyclin A/cyclin B1
is specific for S54, as there are several other S/TP mo-
tifs in the N-myc protein, but mutation of S54 to A abol-
ished the activity of the Cdk1/cyclin A/cyclin B1 immu-
noprecipitates toward N-myc.
To determine whether our in vitro kinase assay results
reflect mechanisms regulating endogenous N-myc S54
phosphorylation in SJ8 cells, we tested specific inhibi-
tors of Cdk and Erk. We treated SJ8 cells with ndz (9 hr)
to promote increased MYCN phosphorylation, and we
concurrently treated with roscovitine or PD98059, in-
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Cibitors of Cdks and erk, respectively. As shown in Fig-
re 4B, PD98059 had little effect on S54 phosphoryla-
ion. Reduced Erk activity was evident, as determined
y decreased Erk phosphorylation. Thus, Erk appears
ot to phosphorylate N-myc at S54 in cells arrested in
2/M.
The Cdk inhibitor roscovitine markedly reduced
evels of N-myc phosphorylated at S54 (Figure 4B), sug-
esting that a Cdk mediates N-myc S54 phosphoryla-
ion. Prolonged treatment with roscovitine itself can af-
ect cell cycle progression, and it thus may indirectly
ffect cell cycle-dependent N-myc phosphorylation.
herefore, we treated SJ8 cells with ndz alone to permit
ccumulation of cells in G2/M, then we acutely treated
hem with roscovitine. As shown in Figure 4C, cells ar-
ested in G2/M were detectable after 3 hr of ndz treat-
ent and accumulated over the course of 9 hr. SJ8
ells arrested in G2/M showed evidence of decreased
YCN protein, while S54 phosphorylation increased.
rief treatment with roscovitine resulted in decreased
54 phosphorylation. These results, combined with our
n vitro kinase assays and correlation of increased
dk1/cyclin A/cyclin B1 activity with increased MYCN
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333S54 phosphorylation, strongly suggest that the Cdk1
complex is involved in N-myc S54 phosphorylation.
SJ8 cells were infected with lentiviruses expressing
a small hairpin (sh) RNA specific for human Cdk1 (Fig-
ure S2) and were then treated with ndz at various time
points. Sh-Cdk1-infected cells arrested in G0 over time,
with corresponding decreases in levels of Cdk1 (Figure
4D). When control-infected cells were treated with ndz
for 3 hr, we observed increased levels of S54 phosphor-
ylation and decreased MYCN protein. In contrast, SJ8
cells in which Cdk1 was knocked down showed a pro-
gressive decrease in S54 phosphorylation in the presence
of ndz, with an associated lack of MYCN destabilization.
We did not observe a tendency toward increased overall
levels of MYCN in Cdk1 knockdown SJ8 cells. Additional
mechanisms regulating myc stability have been pro-
posed (see Discussion); it is possible that these mecha-
nisms may adapt to accommodate long-term disabling
of phosphorylation-mediated MYCN turnover in neuro-
blastoma cells.
Cdk2 is closely related to Cdk1, and cyclin A can
function with Cdk2 in S phase (Pagano et al., 1992). We
assessed the ability of Cdk2 to phosphorylate wild-type
N-myc or N-myc S54A in asynchronously cycling SJ8
cells or in SJ8 cells arrested at the G1/S boundary by
aphidicolin. As shown in Figure 4E, Cdk2 was able to
phosphorylate the wild-type N-myc substrate in vitro.
However, Cdk2 also phosphorylated the N-myc S54A
substrate, indicating that, like Cdk5, its activity is not
specific for S54. Moreover, protein lysates prepared
from aphidicolin-treated cells showed no evidence of
increased N-myc S54 phosphorylation, suggesting that
cyclin E:Cdk2 or cyclin A:Cdk2 do not phosphorylate
S54 in living cells. Interestingly, we observed slightly
reduced N-myc levels in aphidicolin-treated cells, in
keeping with reports of an S phase-specific, phosphor-
ylation-independent mechanism regulating myc turn-
over (Kim et al., 2003; von der Lehr et al., 2003). The
comparatively profound loss of N-myc and high levels
of S54 phosphorylation in G2/M-arrested SJ8 cells un-
derscore the potency of phosphorylation as a mecha-
nism for regulating N-myc levels. These results indicate
that, although cyclin A is active during the G1/S transi-
tion, it does not direct Cdk2 activity toward N-myc.
Cyclins A and B1 Are Expressed
in Proliferating CGNPs
Our experiments conducted in SJ8 neuroblastoma cells
strongly support an important role for Cdk1 in regulat-
ing S54 phosphorylation. To determine whether the
Cdk1 complex phosphorylates N-myc in the developing
CNS, we analyzed N-myc S54 phosphorylation and
cyclin B1 localization in the external granule layer of
the developing mouse cerebellum and cultured CGNPs.
As shown in Figure 5A, N-myc phosphorylated on S54
appeared in CGNPs undergoing mitosis, as evidenced
by chromosome condensation. Cyclin B1 has pre-
viously been identified as an indirect downstream tar-
get of the Shh signaling pathway in cultured CGNPs
(Zhao et al., 2002). Consistent with these findings, we
observed cyclin B1 mRNA expression in the outer layer
of the cerebellar EGL (Figure 5A, right panel), where
CGNPs express N-myc (Kenney and Rowitch, 2000)and are actively proliferating. As shown in Figure 5B,
cyclin B1 protein was restricted to the cytoplasm of
CGNPs in the EGL, except in cells featuring mitotic fig-
ures (arrows, left panel). Cells with nuclear cyclin B1
corresponded to cells with N-myc phosphorylated at
S54 (center, right panels). In vitro, mitotic CGNPs were
positive for both cyclin B1 and phosphorylated N-myc
(Figure 5C). In interphase cells, cyclin B1 was localized
to the cytoplasm, and S54-phosphorylated N-myc was
not detected.
Cyclin A is also indirectly regulated by Shh (Zhao et
al., 2002) in proliferating CGNPs. We performed immuno-
staining, together with staining for the mitotic marker
phospho-histone H3, for cyclin A in Shh-treated CGNPs.
We detected cyclin A in both mitotic and interphase
cells (Figure 5C), consistent with the ability of cyclin A
to act during multiple phases of the cell cycle (Pagano
et al., 1992). Thus, cyclin A and cyclin B are spatiotem-
porally localized for mediating mitotic N-myc phos-
phorylation in CGNPs.
The Cdk1 Complex Phosphorylates N-Myc
in CGNPs
As shown in Figure 6A, N-myc and cyclin D2 protein
levels were upregulated in Shh-treated CGNPs, consis-
tent with Shh mitogenic effects on CGNPs. In associa-
tion, we observed markedly increased levels of cyclin A
and cyclin B1 and phosphorylated Cdk1 in Shh-treated
CGNPs, compared with vehicle-treated CGNPs. These
observations suggest that the Cdk1 complex is active
in proliferating Shh-stimulated GCNPs, but not in vehi-
cle-treated differentiating CGNPs. As previously re-
ported (Kenney and Rowitch, 2000), Shh treatment did
not have effects on Erk activity. In in vitro kinase as-
says, Cdk1, cyclin A, and cyclin B1 immunoprecipitated
from vehicle-treated CGNPs showed little activity. How-
ever, Cdk1, cyclin A, and cyclin B1 immunoprecipitated
from Shh-treated cells phosphorylated the full-length
GST-N-myc substrate. Ndz treatment (3 hr) increased
the activity of the immunoprecipitates (Figure 6B), con-
sistent with its ability to promote increased numbers
of G2/M-arrested cells. Longer treatment with ndz was
toxic (data not shown).
As shown in Figure 6C, acute roscovitine treatment
after ndz exposure reduced the levels of S54 phosphor-
ylation. These data suggest that Cdk1 activity is re-
quired for mitosis-associated phosphorylation of N-myc
at S54 in primary CGNPs. CGP74514A is highly selec-
tive for Cdk1 (Imbach et al., 1999) and has potent ef-
fects on Cdk1 activity in human leukemia cells (Dai et
al., 2002; Yu et al., 2003). CGP74514A also strongly in-
hibited N-myc S54 phosphorylation (Figure 6C). Both
roscovitine and CGP74514A caused a partial recovery
of N-myc levels. Total recovery of N-myc stability in the
presence of Cdk inhibitors is not expected, because
Cdk inhibitors may also inhibit RNA translation (Fischer,
2004), and phosphorylation-independent mechanisms
regulating myc turnover exist (see Discussion). Erk inhi-
bition did not notably affect N-myc S54 phosphoryla-
tion or prevent N-myc protein level decline in G2/M-
arrested CGNPs.
To determine whether the reduction in levels of N-myc
protein observed in G2/M-arrested primary neural pre-
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Mitotis phases of immunostained cells are: P, prophase; P/M, prometaphase; M, metaphase; A, anaphase; C, cytokinesis; I, Interphase.
(A) The left panel schematic illustrates a PN7 cerebellar sagittal section. Granule neuron precursor proliferation occurs postnatally in the
external granule layer (EGL), in response to Sonic hedgehog secreted by Perkinje neurons in the molecular layer (Mol). To complete differentia-
tion, CGNPs migrate into the internal granule layer (IGL). The center panel shows anti-phospho-S54 N-myc (red) in mitotic SW129 mouse-
derived cells, similar to our observations in BL6 pups (Figure 3). Dapi staining (blue) was used to identify nuclei. The arrow indicates the
direction of granule neuron precursor migration. The right panel shows cyclin B1 expression in the EGL. The zones where proliferation levels
are highest (“a”) and reduced (“b”) are indicated.
(B) Cyclin B1 (green)/S54-phosphorylated N-myc (red) immunostaining in a P7 mouse cerebellum shows colocalization to mitotic cells. The
left panel shows cyclin B1 alone. The central panel shows cyclin B1 and the phospho-S54 N-myc merge, low power. The right panel, a high-
power image, shows cyclin B1 and S54-phosphorylated N-myc in a metaphase cell and cytoplasmic cyclin B1 in an interphase cell.
(C) Immunofluorescent staining of cultured Shh-treated CGNPs for S54-phosphorylated N-myc (red) and cyclin B1 (green), and Dapi (blue)
shows colocalization of cyclin B1 and phospho-S54 N-myc in late-prophase and metaphase cells. Cyclin B1 was cytoplasmic in interphase
cells (I). The right panel shows immunostaining for cyclin A (red) and phospho-histone H3 (green) in Shh-treated CGNPs. Nuclei are stained
with Dapi (blue).cursors is due to proteolysis, we treated CGNPs with
ndz in the presence or absence of the proteosome in-
hibitor, lactacystin. Lactacystin prevented N-myc pro-
tein downregulation in ndz-treated cells (Figure 6D). We
observed T50-phosphorylated N-myc in the presence
of lactacystin, consistent with T50 phosphorylation sig-
naling for N-myc degradation.
Protein turnover during mitosis is also regulated by
the anaphase-promoting complex (APC). N-myc amino
acids 116–124 comprise a canonical “D box” sequence
for interacting with the APC/cdc20 (Zachariae, 2004)
that is not present in c-myc. Both N-myc and c-myc
possess a partial D box (amino acids 384–387 in N-myc)
that overlaps with the basic domain. We made N-myc
retroviruses mutated in either the N-myc-specific D box
or the partial D box. CGNPs were infected with these
retroviruses, and the relative stability of N-myc or mu-
tant N-myc in the presence of ndz was assessed. The
D box mutations did not confer stability upon N-myc in
the presence of ndz (Figure 6E and data not shown).
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thus, N-myc’s D box or partial D box does not play a
ritical role in N-myc destabilization during mitosis. We
annot rule out interactions between the APC and other
s yet uncharacterized recognition sequences.
Our data show that S54 phosphorylation is associ-
ted with N-myc destabilization in mitotic CGNPs. We
nfected CGNPs with retroviruses expressing wild-type
-myc or N-myc S54A, and we compared their stability
n the presence of ndz. Wild-type N-myc levels were
educed in the presence of ndz (Figure 6F). N-myc S54A
evels were not affected by arrest in G2/M. These re-
ults suggest that N-myc destabilization in mitotic pri-
ary neural precursors requires S54 phosphorylation.
iscussion
ell Cycle-Dependent Regulation of N-Myc
urnover during CNS Development
e have investigated phosphorylation-dependent N-myc
urnover during cerebellar development. We found that
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335Figure 6. N-Myc S54 Phosphorylation Is
Regulated by the Cdk1 Complex in CGNPs
(A) Western blot analysis of cell cycle regula-
tors in CGNPs treated with Shh vehicle or
Shh for 24 hr as indicated.
(B) Cyclin A, cyclin B1, and Cdk1 immuno-
precipitated from Shh-treated CGNPs phos-
phorylate full-length GST-N-myc in vitro. In-
creased N-myc phosphorylation is seen in
the presence of ndz. Flow cytometry indi-
cates CGNP cell cycle distribution.
(C) Cdk inhibition results in decreased N-myc
S54 phosphorylation. CGNPs were treated
with Shh for 24 hr before the addition of ndz
for 3 hr. Roscovitine, CGP74514A, or PD98059
was added for 1 hr. The distribution of cells
in G1 and G2/M, determined by flow cyto-
metry, is indicated below the Western blots.
(D) Proteosome inhibition prevents N-myc
decreases in G2/M-arrested CGNPs. Cells
were maintained in the presence or absence
of Shh, then treated with ndz ± lactacystin
as indicated. T50-phosphorylated N-myc can
be detected in lactacystin-treated cells, sug-
gesting that this form of N-myc is degraded
in G2/M-arrested CGNPs.
(E) Mutating a potential APC recognition se-
quence conserved between N- and c-myc
does not prevent ndz-induced N-myc desta-
bilization in CGNPs. Cells were infected with
retroviruses as indicated, then treated with
ndz 24 hr postinfection before Western
blotting.
(F) CGNPs were infected with retroviruses as
indicated, then treated with ndz 24 hr postin-
fection. Wild-type N-myc decreases in ndz,
accompanied by S54 phosphorylation, while
N-myc S54A is not affected by ndz treatment
and is not phosphorylated.increased S54 phosphorylation is strongly associated
with N-myc destabilization. Further, we show that the
mitotic kinase Cdk1, in complex with cyclins A and B1,
mediates N-myc S54 phosphorylation in primary CGNPs.
N-myc is thus primed for GSK-3β-mediated phosphoryla-
tion, which promotes degradation of c-myc and other cell
cycle regulatory proteins (Diehl et al., 1998; Welcker et
al., 2003, 2004). Our model is consistent with permitting
primary neural precursor exit from the cell cycle before
G1 is reentered. This allows differentiation to begin, in
accordance with intrinsic programs (Figure 7).
Our data indicate an increase in phosphorylation-
associated N-myc degradation during mitosis, which
occurs over an interval of less than 1 hr. N-myc is a
short-lived protein with a half-life of approximately 40
min, while the cell cycle in mouse CGNPs at PN4 lasts
16–18 hr (Mares et al., 1970). How is N-myc disposed
of during interphase in proliferating CGNPs? There is
growing evidence that myc protein stability regulation
may also involve regions outside of the amino-terminal
myc box 1 domain containing T50 and S54 (Alarcon-
Vargas et al., 2002; Herbst et al., 2004). Interactions be-
tween the myc box 2 domain and the F box protein
Skp2 promote c-myc proteolysis during the G1-to-S
phase transition (Kim et al., 2003; von der Lehr et al.,
2003), indicating that myc metabolism may be regu-
lated in a cell cycle-dependent manner. With regard toN-myc, these mechanisms have yet to be verified in
primary neural precursors.
GSK-3-Mediated N-Myc Destabilization
Is Primed by the Cdk1 Complex
GSK-3β-mediated phosphorylation targets c-myc for
degradation through a mechanism involving the F box
protein Fbw7 in a variety of cell lines (Welcker et al.,
2004). A similar mechanism for N-myc degradation was
suggested. Whether Fbw7, or another F box protein
with an appropriate spatiotemporal expression pattern,
plays a role in N-myc proteolysis in primary cells and
during cerebellar development in vivo remains to be de-
termined. To act upon N-myc at T50, GSK-3β must first
be primed by phosphorylation at S54. Basal levels of
N-myc S54 phosphorylation could be mediated by non-
mitotic kinases, such as Erk, outside mitosis. We also
identified N-myc as a substrate for the neural-specific
kinase Cdk5. However, neither Erk nor Cdk5 activity
was specific for S54. We found that the Cdk1 complex
contains a potent, specific N-myc S54 kinase.
Cdk1 heterodimerizes with cyclin A and cyclin B1.
Cell-free in vitro assays have shown that cyclin A in
complex with Cdk1 and p107 can phosphorylate GST-
c-myc fusion proteins (Hoang et al., 1995). Both cyclin
A and cyclin B1 immunoprecipitated specific activity
toward N-myc, and both cyclins are expressed in Shh-
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336Figure 7. Model Suggesting How Shh Influences Neuronal Precur-
sor Progression through G1, Mitosis, and Entry into the Next Round
of Division
Shh directly induces N-myc expression and indirectly affects N-myc
posttranslational modification, mediated by its indirect targets,
cyclins A and/or B. Mitotic degradation of N-myc permits neuronal
precursor cell cycle exit in the absence of Shh signaling or in the
case of an intrinsic program-directed shift toward differentiation.
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dtreated CGNPs during mitosis. Cyclin A was also found
in interphase CGNPs, consistent with its participation
in Cdk2 complexes during S phase (Pagano et al.,
1992). The lack of S54 phosphorylation in G1/S-
arrested cells indicates that cyclin A:Cdk2 does not
phosphorylate N-myc. Although cyclin A:Cdk1 com-
plexes may have some substrates distinct from those
of cyclin B:Cdk1 complexes (Peeper et al., 1993), it has
been shown that many Cdk substrates are indifferent
as to the cyclin subunit of the cyclin:Cdk1 complex
(Loog and Morgan, 2005). Our analyses suggest that,
in primary CGNPs, N-myc S54 can be targeted by either
cyclin A:Cdk1 or cyclin B1:Cdk1.
Regulation of N-Myc in Primary Neuronal
Precursors and Cancer
Early studies reported that c-myc protein synthesis and
modification is not altered during mitosis (Hann et al.,
1985). Later studies demonstrated mitosis-specific c-myc
phosphorylation (Luscher and Eisenman, 1992). These
studies were carried out in cell lines with flexible cell cycle
exit and reentry capacity. Our work with N-myc has been
conducted in primary neuronal precursors with a de-
fined intrinsic program for irreversible cell cycle exit and
subsequent differentiation (Altman and Bayer, 1997; Dur-
and and Raff, 2000). Many previous myc turnover
studies have relied on overexpression, while we have
focused on regulation of endogenous N-myc stability,
in primary cultures and in vivo. Our finding that N-myc
is largely degraded at the conclusion of the primary
neural precursor cell cycle provides insight as to how
enhanced stability of N-myc protein can contribute to
brain tumorigenesis, by enhancing CGNPs’ capacity for
ongoing division. Increased activity of IGF2, which is
predicted to stabilize N-myc, is associated with in-
creased proliferation in primary neural precursors and
in mouse and human medulloblastomas (Hartmann et
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dl., 2005; Rao et al., 2004; Wang et al., 2001). Thus,
uture analysis of how N-myc turnover is regulated dur-
ng CGNP expansion in vivo will yield greater under-
tanding of normal brain development and brain tu-
or biology.
xperimental Procedures
ell Culture and Virus Production
rimary cultures of postnatal day (PN) 4/5 SW129 mouse CGNPs
ere established as described (Kenney et al., 2004). For immuno-
ytochemistry experiments, cell suspensions were subjected to
ercoll gradient centrifugation before plating on poly-ornithine-
oated glass coverslips. Cultures were maintained in serum-free
edium containing only vehicle or Shh (Biogen) for 24 hr prior to
reatments (Supplemental Experimental Procedures).
HEK293 cells (Invitrogen) were maintained in DMEM + 10% fetal
alf serum, with antibiotics. Production of and infection with WZL
etroviruses expressing wild-type N-myc, N-myc T50A, or N-mycS54A
as carried out as previously described (Kenney et al., 2004). Wzl
-mycpartDbox (R384A, L387A) and WzlN-mycDbox (R116A,
119A, N124A) were made by using Quick-change site-directed
utagenesis (Stratagene). SJ8 neuroblastoma cells (Teitz et al., 2000)
ere maintained in RPMI + 10% fetal calf serum, with antibiotics.
For making Cdk1-specific shRNA lentiviruses, we obtained five
ifferent pLKO.1-cdc2 constructs from The RNAi Consortium (TRC,
ttp://www.broad.mit.edu/cell/trc). Each construct was assessed
or its ability to produce lentiviruses capable of functional knock-
own of cdc2 in human neuroblastoma cells (Figure S2).
rotein Preparation and Western Blotting
rotein extracts were prepared and processed for SDS-PAGE as
reviously described (Kenney and Rowitch, 2000; Matsushime et
l., 1994). Western blotting was performed according to standard
ethods (Supplemental Experimental Procedures). Rabbit poly-
lonal antibodies against phospho-S54 N-myc S54/phospho-
-myc S62 were generated at Bethyl, Inc., by using the peptide
ELLPTPPL(pS)PSRAFPEH as an immunogen. For competition as-
ays, antibodies were incubated in 5% milk with a 4-fold molar
xcess of peptide for 1 hr at 4°C before addition to the membrane.
GST-Pin1 pull-down assays were carried out as described (Shen
t al., 1998), by using 50–100 g protein from vehicle, Shh-treated,
r retrovirally infected CGNPs. Lysates were incubated with GST-
in1 beads or GST beads alone for 2 hr at 4°C. Following washes,
eads were boiled in SDS-PAGE sample buffer and separated on
% polyacrylamide gels for Western blot analysis.
mmune Complex Kinase Assays
rotein lysates were prepared as described above. Kinase assays
ere carried out precisely as described (Matsushime et al., 1994)
ith 200 g lysate. See Supplemental Experimental Procedures for
ntibodies and specific reaction conditions. Results shown are rep-
esentative of experiments carried out in triplicate.
low Cytometry for Cell Cycle Analysis
dherent and floating cells were fixed in ethanol and stained with
ropidium iodide according to standard methods (Kenney and
owitch, 2000). Fluorescence was determined by flow cytometry
y using a FACScan (Becton Dickinson) and Cellquest software
Becton Dickinson) for acquisition. Modfit software (Verity Software
ouse) was used for quantifying cell cycle phase distribution. Data
escribed in the accompanying text are representative of results
rom experiments performed in triplicate.
mmunofluorescent Staining of Cultured Cells
nd Cerebellar Sections
issociated cerebellar cell preparations were plated on poly-DL-
rnithine-coated glass coverslips, and immunocytochemistry was
erformed as previously reported (Kenney and Rowitch, 2000). For
mmunohistochemistry, 7 M cerebellar sections from paraformal-
ehyde-perfused PN7 SW129 pups were used. Standard condi-
N-Myc Phosphorylation/Turnover in Mitosis
337tions, including antigen retrieval, were used. See Supplemental Ex-
perimental Procedures for immunostaining details and antibodies.
Pin1 Null Mouse Analysis
PCR genotyping was used to identify Pin1 mutant and wild-type
littermates (BL6 background) at PN5. BrdU injection was performed
as described (Kenney and Rowitch, 2000). After 1 hr, pups were
perfused with 4% paraformaldehyde, and the cerebella were dis-
sected out and postfixed for 24 hr in 4% paraformaldehyde, before
embedding in OCT. Cerebella were sectioned and processed for
immunostaining as described above. For analysis of proliferation
markers, three midline sections of Pin1 mutant and wild-type litter-
mates were selected. Such sections from three separate litters
were analyzed by a blind observer.
Cyclin B1 In Situ Hybridization
Mouse cyclin B1 cDNA fragment was cloned into pGEM-T (Pro-
mega), linearized with Sal1, and transcribed with T7 polymerase
by using a digoxygenin (DIG) RNA labeling kit, according to the
manufacturer’s instructions (Roche), to generate an antisense RNA
probe. PN5 SW129 pups were perfused with 4% paraformalde-
hyde, and cerebellar sections were prepared as described above.
In situ hybridization and image capturing were carried out as de-
scribed (Zhao et al., 2002).
Supplemental Data
Supplemental Data including figures and Supplemental Experimen-
tal Procedures are available at http://www.developmentalcell.com/
cgi/content/full/9/3/327/DC1/.
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